Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Ambrx Biopharma Quick Ratio 2020-2022 | AMAM

Historical quick ratio values for Ambrx Biopharma (AMAM) over the last 10 years.
  
Ambrx Biopharma Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2022-06-30 $0.00B $0.03B 0.00
2021-12-31 $0.00B $0.03B 0.00
2021-06-30 $0.00B $0.02B 0.00
2020-12-31 $0.00B $0.01B 0.00
2019-12-31 $0.00B $0.02B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.335B $0.007B
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $140.576B 8.70
GSK (GSK) United Kingdom $75.923B 9.52
Bio-Rad Laboratories (BIO.B) United States $13.735B 32.61
QIAGEN (QGEN) Netherlands $10.436B 19.34
Ginkgo Bioworks Holdings (DNA) United States $2.549B 0.00
Arcus Biosciences (RCUS) United States $1.194B 0.00
Biohaven (BHVN) United States $0.913B 0.00
Emergent Biosolutions (EBS) United States $0.394B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.152B 0.00
Enzo Biochem (ENZ) United States $0.106B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.012B 0.00